Bristol-Myers Squibb Pharmaceuticals Ltd

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677
Patient Information Leaflet last updated on the eMC: 21/08/2009
PIL CoAprovel 150 mg/12.5 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 04/12/2008 and displayed until 21/08/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/08/2008 and displayed until 04/12/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   hydrochlorothiazide
   irbesartan


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk